Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page
Users Online: 3641

 Table of Contents  
Year : 2014  |  Volume : 11  |  Issue : 2  |  Page : 85

Screening for thyroid dysfunction during pregnancy

1 Department of Endocrine and Diabetes, 1st November 1954 University Hospital, Oran, Algeria
2 Department of Endocrine and Metabolic Diseases, Bab El Oued Hospital, Algiers, Algeria

Date of Web Publication31-Mar-2014

Correspondence Address:
Mohammed El Amine Amani
1st November 1954 University Hospital, BP No 4166 Ibn Rochd, Oran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0973-0354.129742

Rights and Permissions

How to cite this article:
Amani ME, Chentli F. Screening for thyroid dysfunction during pregnancy. Thyroid Res Pract 2014;11:85

How to cite this URL:
Amani ME, Chentli F. Screening for thyroid dysfunction during pregnancy. Thyroid Res Pract [serial online] 2014 [cited 2022 Jun 30];11:85. Available from: https://www.thetrp.net/text.asp?2014/11/2/85/129742


We read with great interest of your article entitled "Screening for thyroid dysfunction during pregnancy" by Shah, et al., [1] the issue of May-August 2013. We would like to make our contribution in the light of our modest experience.

It is now well established that any thyroid abnormality in the mother may be harmful for both the course of the pregnancy and the somatic and neurological development of the fetus.

As reported by Shah et al., [1] many societies do not recommend universal screening of the thyroid dysfunctions during pregnancy, except in pregnant women with risk factors. Shah et al., [1] found that 92% of hypothyroid pregnant women and 87.5% of hyperthyroid ones had no risk factors. Otherwise, many studies around the world, as reported by the author, showed that the percentage of dysthyroid women with no risk factor were about 30-80% for hypothyroidism and 80-88% for hyperthyroidism. [2],[3],[4],[5] These results interpel us when we know the terrible consequences of thyroid dysfunction as reported above. These findings led Shah et al., [1] to recommend universal screening of thyroid abnormalities in the preconception or in early pregnancy with a measurement of TSH, attitude that we adhere completely because TSH assay is simple, reliable, available, and low cost, also in order not to omit dysthyroid pregnant women and leave them without treatment, therefore, being exposed to complications.

  References Top

1.Shah JM, Mehta MN, Viradia HB. Screening for thyroid dysfunction during pregnancy. Thyroid Res Pract 2013;10:65-7.  Back to cited text no. 1
  Medknow Journal  
2.Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab 2011;96:E1452-6.  Back to cited text no. 2
3.Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I, et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010;163:645-50.  Back to cited text no. 3
4.Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L, et al. The prevalence of thyroid disorders during early pregnancy in China: The benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol 2011;164:263-8.  Back to cited text no. 4
5.Dosiou C, Sanders GD, Araki SS, Crapo LM. Screening pregnant women for autoimmune thyroid disease: A cost-effectiveness analysis. Eur J Endocrinol 2008;158:841-51.  Back to cited text no. 5


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded200    
    Comments [Add]    

Recommend this journal